These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 21517709)

  • 41. Pharmacologic management of relapse prevention in addictive disorders.
    Sofuoglu M; Kosten TR
    Psychiatr Clin North Am; 2004 Dec; 27(4):627-48. PubMed ID: 15550284
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The effect of FDA approval of a generic competitor to OxyContin (oxycodone HCl controlled-release) tablets on the abuse of oxycodone.
    Bailey JE; Barton PL; Lezotte D; Lowenstein SR; Dart RC
    Drug Alcohol Depend; 2006 Sep; 84(2):182-7. PubMed ID: 16510252
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A reassessment of trends in the medical use and abuse of opioid analgesics and implications for diversion control: 1997-2002.
    Gilson AM; Ryan KM; Joranson DE; Dahl JL
    J Pain Symptom Manage; 2004 Aug; 28(2):176-88. PubMed ID: 15276196
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The painkiller prescription: protect use, prevent abuse.
    Sullivan LW
    Med Econ; 2001 Sep; 78(17):18-9. PubMed ID: 11573391
    [No Abstract]   [Full Text] [Related]  

  • 45. Non-medical use and abuse of commonly prescribed medications.
    Riggs P
    Curr Med Res Opin; 2008 Mar; 24(3):869-77. PubMed ID: 18267053
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A flood of opioids, a rising tide of deaths.
    Okie S
    N Engl J Med; 2010 Nov; 363(21):1981-5. PubMed ID: 21083382
    [No Abstract]   [Full Text] [Related]  

  • 47. Relative abuse potential of opioid formulations in Canada: a structured field study.
    Sellers EM; Schuller R; Romach MK; Horbay GL
    J Opioid Manag; 2006; 2(4):219-27. PubMed ID: 17319483
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Prevalence of opioid analgesic injection among rural nonmedical opioid analgesic users.
    Havens JR; Walker R; Leukefeld CG
    Drug Alcohol Depend; 2007 Feb; 87(1):98-102. PubMed ID: 16959437
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Formulation considerations for the development of medications with abuse potential.
    Mansbach RS; Moore RA
    Drug Alcohol Depend; 2006 Jun; 83 Suppl 1():S15-22. PubMed ID: 16472940
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Fentanyl intoxication caused by abuse of transdermal fentanyl.
    Moon JM; Chun BJ
    J Emerg Med; 2011 Jan; 40(1):37-40. PubMed ID: 18455903
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Nonmedical use of prescription opioids: furthering a meaningful research agenda.
    Fischer B; Rehm J
    J Pain; 2008 Jun; 9(6):490-3; discussion 494-6. PubMed ID: 18514135
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Managing pain in patients with aberrant drug-taking behaviors.
    Passik SD; Kirsh KL
    J Support Oncol; 2005; 3(1):83-6. PubMed ID: 15724951
    [No Abstract]   [Full Text] [Related]  

  • 53. National addictions vigilance intervention and prevention program (NAVIPPRO): a real-time, product-specific, public health surveillance system for monitoring prescription drug abuse.
    Butler SF; Budman SH; Licari A; Cassidy TA; Lioy K; Dickinson J; Brownstein JS; Benneyan JC; Green TC; Katz N
    Pharmacoepidemiol Drug Saf; 2008 Dec; 17(12):1142-54. PubMed ID: 18932173
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Palatal perforation associated with intranasal prescription narcotic abuse.
    Jewers WM; Rawal YB; Allen CM; Kalmar JR; Fox E; Chacon GE; Sedghizadeh PP
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2005 May; 99(5):594-7. PubMed ID: 15829883
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Opioid analgesic involvement in drug abuse deaths in American metropolitan areas.
    Paulozzi LJ
    Am J Public Health; 2006 Oct; 96(10):1755-7. PubMed ID: 17008568
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The Minnesota Prescription Monitoring Program.
    Herman C
    Northwest Dent; 2011; 90(2):33-5. PubMed ID: 21667591
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Assessing the prevalence of opioid misuse, abuse, and addiction in chronic pain.
    Ballantyne JC
    Pain; 2015 Apr; 156(4):567-568. PubMed ID: 25630030
    [No Abstract]   [Full Text] [Related]  

  • 58. Substance abuse and withdrawal in the critical care setting.
    Tetrault JM; O'Connor PG
    Crit Care Clin; 2008 Oct; 24(4):767-88, viii. PubMed ID: 18929942
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Addiction.
    Baysinger A; Gianessi C
    Yale J Biol Med; 2015 Sep; 88(3):203-4. PubMed ID: 26571547
    [No Abstract]   [Full Text] [Related]  

  • 60. Foundations of opioid risk management.
    Katz NP; Adams EH; Benneyan JC; Birnbaum HG; Budman SH; Buzzeo RW; Carr DB; Cicero TJ; Gourlay D; Inciardi JA; Joranson DE; Kesslick J; Lande SD
    Clin J Pain; 2007 Feb; 23(2):103-18. PubMed ID: 17237659
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.